SUN PHARMACEUTICAL INDUSTRIES
Back to Cashflow Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-1,437 Cr | ₹860 Cr | ₹4,735 Cr | ₹-608 Cr | ₹-1,934 Cr |
What is the latest Net Cash Inflow / Outflow ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-1,437 Cr |
| Mar2025 | ₹860 Cr |
| Mar2024 | ₹4,735 Cr |
| Mar2023 | ₹-608 Cr |
| Mar2022 | ₹-1,934 Cr |
How is Net Cash Inflow / Outflow of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-1,437 Cr | Negative | |
| Mar2025 | ₹860 Cr | -81.83 | |
| Mar2024 | ₹4,735 Cr | Positive | |
| Mar2023 | ₹-608 Cr | Negative | |
| Mar2022 | ₹-1,934 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,066.7 Cr | 7.3% | 8.4% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 15.3% | 24.1% | 63% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 1% | 2.5% | 33.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | 1% | 15.9% | 14% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 0.4% | 7.9% | -6.2% | Stock Analytics | |
| MANKIND PHARMA | ₹109,911.0 Cr | 5.1% | 12.3% | 8.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 7.3% |
8.4% |
13.1% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses